Asoy, Jonelyn G.
HRN: 28-91-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
MUPIROCIN 2%, 15G (TUBE)
06/22/2026
06/28/2026
TOPICAL
2%
OD
SP CS
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: